【24h】

European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori.

机译:欧洲对幽门螺杆菌体外抗药性的多中心调查。

获取原文
获取原文并翻译 | 示例
           

摘要

A multicentre in vitro survey was carried out in 1998 in 22 European centres in order to assess the variation in the prevalence of Helicobacter pylori resistance. The susceptibility of 1,274 isolates to metronidazole, clarithromycin and amoxicillin was determined by the E test. The mean rate of resistance to metronidazole was 33.1% (95% CI, 7.5-58.9), to clarithromycin 9.9% (95% CI, 0-28.1) and to amoxicillin 0.8% (95% CI, 0-8.9). Resistance to metronidazole was significantly higher in females (P<0.001), while resistance to clarithromycin was significantly higher in children and teens (P<0.05). Resistance to both agents also tended to be higher in strains isolated from patients from southern European countries than in those isolated from patients from central or northern Europe. Overall, these results emphasize the need for further surveys of Helicobacter pylori sensitivity to antibiotics at a national and regional level.
机译:1998年,在欧洲的22个中心进行了一次多中心体外调查,以评估幽门螺杆菌耐药性发生率的变化。通过E检验确定了1,274个分离株对甲硝唑,克拉霉素和阿莫西林的敏感性。对甲硝唑的平均耐药率为33.1%(95%CI,7.5-58.9),对克拉霉素9.9%(95%CI,0-28.1)和对阿莫西林的0.8%(95%CI,0-8.9)。女性对甲硝唑的抵抗力明显较高(P <0.001),而儿童和青少年对克拉霉素的抵抗力明显较高(P <0.05)。从南欧国家的患者分离的菌株对两种药物的抗药性也往往比从中欧或北欧的患者分离的菌株高。总体而言,这些结果强调需要在国家和地区水平上进一步调查幽门螺杆菌对抗生素的敏感性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号